期刊文献+

糖皮质激素联合丙球蛋白治疗特发性血小板减少性紫癜患儿的临床研究 被引量:38

Clinical effect of glucocorticoid combined with gamma globulin in the treatment of idiopathic thrombocytopenic purpura
原文传递
导出
摘要 目的观察糖皮质激素联合丙球蛋白治疗特发性血小板性紫癜患儿的临床疗效。方法 40例特发性血小板减少性紫癜患儿随机为试验组和对照组,各20例。对照组初期静脉滴注甲泼尼龙5~8 mg·kg^(-1)·d^(-1),血小板计数恢复正常后改为口服泼尼松2 mg·kg^(-1)·d^(-1);试验组在对照组基础上静脉滴注丙球蛋白400 mg·kg^(-1)·d^(-1),2组疗程均为1个月,并随访3个月。比较2组患儿的临床疗效、血小板开始上升时间和血小板到达峰值时间。结果试验组显效率为90.0%,总有效率为95.0%,显著高于对照组的65.0%,85.0%(P<0.05)。试验组血小板开始上升时间和血小板到达峰值时间分别为(3.4±1.6),(8.1±3.1)d,显著短于对照组的(5.0±1.8),(12.9±5.1)d(P<0.05)。2组患儿进行3个月的随访,试验组复发率为0,对照组复发率为46.2%(P<0.01)。结论糖皮质激素联合丙球蛋白的愈后良好,且经济有效。 Objective To investigate the clinical effect of glucocorticoid combined with gamma globulin in the treatment of idiopathic thrombocyto- penic purpura. Methods Forty children with idiopathic thrombocytope- nic purpura were divided into treatment group and control group, 20 ca- ses in each group. Control group was firstly intravenous given methyl- prednisolone 5 -8 mg ·kg-1· d-1, then received oral prednisone 2 mg·kg-1· d-1. On the basis of control group, the treatment group was intravenous given immunoglobulin 400 mg· kg-1· d-1. All patients were treated for 1 month, and followed up for 3 months. The clinical effi- ciency, platelet began to rise time and platelet peak time of the two groups were observed. Results The effective rate and total efficiency of treatment group were 90.0%, 95.0%, significantly higher than those of control group, which were 66. 7%, 85.0% (P 〈0. 05). The platelet began to rise time and platelet peak time in treatment group were (3.4 ± 1.6), (8. 1 ± 3.1 ) d, significantly shorter than those in control group, which were (5.0±1.8), (12.9±5.1) d (P〈0.05). After3 months follow- up, the recurrence rate in treatment group and control group were 0, 46. 2%, with significant difference (P 〈 0. 01 ).Conclusion Glucocorticoid combined with gamma globulin in the treat- ment of idiopathic thrombocytopenic purpura was markedly effective.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第3期218-220,共3页 The Chinese Journal of Clinical Pharmacology
关键词 糖皮质激素 丙球蛋白 特发性血小板减少性紫癜 临床疗效 glucocorticoid gamma globulin idiopathic thrombocytopenic purpura clinical effect
  • 相关文献

参考文献7

二级参考文献68

  • 1王琳,张峰,朱媛媛,李丽珍,马道新,侯明.特发性血小板减少性紫癜患者自身血小板的细胞毒杀伤机制[J].中华医学杂志,2005,85(43):3048-3051. 被引量:9
  • 2刘心,徐欣欣,徐波.特发性血小板减少性紫癜186例[J].实用医学杂志,2006,22(5):565-566. 被引量:8
  • 3谢飞,王鸿利.血管性血友病因子研究进展[J].国际检验医学杂志,2006,27(7):622-624. 被引量:7
  • 4凌云,曹祥山,余自强,罗光华,白霞,苏健,戴兰,阮长耿.CD4^+CD25^+调节性T细胞在特发性血小板减少性紫癜患者中的变化[J].中华血液学杂志,2007,28(3):184-188. 被引量:17
  • 5Imbach Paul, Kuhne Thomas, Signer Erich. Historical aspects and present knowledge of idiopathic thromboey- topenic purpura [J]. British Journal of Haematology, 2002,119(4) :894 900.
  • 6Mcmillan R.The pathogenesis of chronic immune thrombocytopenic purpura[J].Semin Hematol,2007,44(4 Suppl 5):S3.
  • 7Tomer A,Friese P,Conklin R,et al.Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts[J].Blood,1989,74(2):594.
  • 8Tomer A.Human marrow megakaryocyte differentiation:multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes[J].Blood,2004,104(9):2722.
  • 9Leven R M.Differential regulation of integrin-mediated proplatelet formation and megakaryocyte spreading[J].J Cell Physiol,1995,163(3):597.
  • 10Leven R M,Tablin F.Extracellular matrix stimulation of guinea pig megakaryocyte proplatelet formation in vitro is mediated through the vitronectin receptor[J].Exp Hematol,1992,20(11):1316.

共引文献38

同被引文献254

引证文献38

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部